Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass II

Sodium Bicarbonate, 8.4% Injectable, 30 mL MultiDose vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (6) 6 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (6) 3 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (2) 3 mg/4.5 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (2)/Theanine 15 mg/5.4 mg/75 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (2) Kit 6 mg/4.5 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (2) 9 mg/9 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (2) & (6) 9 mg/9 mg/9 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate/GHRP (2) & (6) 9 mg/3.15 mg/3.15 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate 9 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate 28 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate 15 mg Injectable Kit., Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

QUAD4 (PAP/PHEN/ALPROS/ATRO) 30 mg/3 mg/60 mcg/0.2 mg/mL Injectable, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

QUAD2 (PAP/PHEN/ALPROS/ATRO) 9 mg/1 mg/10 mg/0.1 mg/mL Injectable a) 2 mL and b) 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Nandrolone Decanote (H), 200 mg/mL Injectable, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

NADH/Carnitine/Taurine/B12(M) Injectable, 100 mg/150 mg/150 mg/10 mg, Lyophilized Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin 40 mg Injectable, Lyophilized (Buffered), 1 mL vial, Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin 20 mg Injectable, Lyophilized (Buffered), 1 mL vial, Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin Solution Injectable, Sterile 0.04%, 400 mcg/mL, 1 mL syringe, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin Solution Injectable, Sterile 0.02%, 200 mcg/mL, 1 mL syringe, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Data last updated: September 25, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.